泰德医药(03880)获中国证监会受理H股全流通计划的申请

智通财经2025-07-27

智通财经APP讯，泰德医药(03880)公布，中国证券监督管理委员会已受理该公司代表公司特定股东向中国证监会提交的关于建议实施H股全流通的申请。根据相关申请文件，公司已申请将公司该等股东所持有每股面值为人民币1.0元的 68,201,112股已发行非上市股份转换为每股面值人民币1.0元的 H股，有关股份占公司于本公告日期已发行股本总额约 48.10%。本次H股全流通完成后，参与本次H股全流通的所有...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2554483327?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-07-27 18:30","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2554483327","market":"fut","top_or_hot":-1,"title":"泰德医药(03880)获中国证监会受理H股全流通计划的申请","media":"智通财经","content":"<div>\n<p>智通财经APP讯，泰德医药(03880)公布，中国证券监督管理委员会已受理该公司代表公司特定股东向中国证监会提交的关于建议实施H股全流通的申请。根据相关申请文件，公司已申请将公司该等股东所持有每股面值为人民币1.0元的 68,201,112股已发行非上市股份转换为每股面值人民币1.0元的 H股，有关股份占公司于本公告日期已发行股本总额约 48.10%。本次H股全流通完成后，参与本次H股全流通的所有...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1322323.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>泰德医药(03880)获中国证监会受理H股全流通计划的申请</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n泰德医药(03880)获中国证监会受理H股全流通计划的申请\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-07-27 18:30 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1322323.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，泰德医药(03880)公布，中国证券监督管理委员会已受理该公司代表公司特定股东向中国证监会提交的关于建议实施H股全流通的申请。根据相关申请文件，公司已申请将公司该等股东所持有每股面值为人民币1.0元的 68,201,112股已发行非上市股份转换为每股面值人民币1.0元的 H股，有关股份占公司于本公告日期已发行股本总额约 48.10%。本次H股全流通完成后，参与本次H股全流通的所有...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1322323.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03880","symbol_name":"泰德医药","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1322323.html","article_id":"2554483327","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2554483327","pubTimestamp":1753612226,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP讯，泰德医药(03880)公布，中国证券监督管理委员会已受理该公司代表公司特定股东向中国证监会提交的关于建议实施H股全流通的申请。根据相关申请文件，公司已申请将公司该等股东所持有每股面值为人民币1.0元的 68,201,112股已发行非上市股份转换为每股面值人民币1.0元的 H股，有关股份占公司于本公告日期已发行股本总额约 48.10%。本次H股全流通完成后，参与本次H股全流通的所有持有非上市股份的股东仍须按照上市规则及适用法律法规的要求，履行股份锁定承诺。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"03880":"泰德医药"},"translate_title":"Tide Pharmaceuticals (03880) received the application accepted by the China Securities Regulatory Commission for the H-share full circulation plan","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03880":1},"content_text":"智通财经APP讯，泰德医药(03880)公布，中国证券监督管理委员会已受理该公司代表公司特定股东向中国证监会提交的关于建议实施H股全流通的申请。根据相关申请文件，公司已申请将公司该等股东所持有每股面值为人民币1.0元的 68,201,112股已发行非上市股份转换为每股面值人民币1.0元的 H股，有关股份占公司于本公告日期已发行股本总额约 48.10%。本次H股全流通完成后，参与本次H股全流通的所有持有非上市股份的股东仍须按照上市规则及适用法律法规的要求，履行股份锁定承诺。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2554483327","isCrawlerRequest":true}